iThe current values are delayed, open demat account for live values.
Nifty Pharma
Nifty Pharma Performance
-
Open
21,769.35
-
High
22,024.30
-
Low
21,721.55
-
Prev Close
21,740.10
-
Dividend Yeild
0.61%
-
P/E
34.69
Nifty Pharma Chart
Stocks Performance
Color code for Stocks Performance
- 5% and above
- 5% to 2%
- 2% to 0.5%
- 0.5% to -0.5%
- -0.5% to -2%
- -2% to -5%
- -5% and below
Constituent Companies
| Company | Market Cap | Market Price | Volume | Sector |
|---|---|---|---|---|
| Abbott India Ltd | ₹58862 Cr |
₹27765
(1.48%)
|
11914 | Pharmaceuticals |
| Cipla Ltd | ₹120033 Cr |
₹1486.5
(0.87%)
|
1978528 | Pharmaceuticals |
| J B Chemicals & Pharmaceuticals Ltd | ₹26935 Cr |
₹1746.55
(0.71%)
|
194962 | Pharmaceuticals |
| Dr Reddys Laboratories Ltd | ₹101286 Cr |
₹1214.45
(0.66%)
|
725089 | Pharmaceuticals |
| Lupin Ltd | ₹94430 Cr |
₹2071.35
(0.39%)
|
1126428 | Pharmaceuticals |
Nifty Pharma Sector Performance
Top Performing
| Sector Name | Percentage Change |
|---|---|
| Diamond, Gems and Jewellery | 0.61 |
| IT - Hardware | 0.29 |
| Leather | 0.94 |
| Ceramic Products | 0.97 |
Under Performing
| Sector Name | Percentage Change |
|---|---|
| Power Generation & Distribution | -0.38 |
| Infrastructure Investment Trusts | -0.13 |
| Printing & Stationery | -0.73 |
| Media - Print/Television/Radio | -0.31 |
Nifty Pharma
The pharma industry’s performance is depicted in the Nifty Pharma Index. 20 NSE-listed companies are included in the Index (NSE).
The level of the Nifty Pharma Index shows the overall free float market valuation of all the companies included in the benchmark with a specific base market cap value. This index is calculated by using the free float market capitalization approach.
The Nifty Pharma Index is utilized for several things, including creating structured products, ETFs, and index funds, as well as benchmarking investment portfolios.
The index was introduced in July 2005, with a reference level of 1000 and a baseline date of January 1st, 2001. The index is recalibrated every two years.
Nifty Pharma Scrip Selection Criteria
- The companies under evaluation must be Nifty 500 members.
- A shortfall amount of stocks will be chosen from the world of securities classified within the leading 800, predicated both on total daily turnover and daily total full market capitalization.
- Businesses must be engaged with the pharmaceutical industry.
- The company’s investing velocity in the previous six months must have been at least 90%.
- The company must have a six-month listing record. If a firm launches an IPO and meets the standard qualifying conditions for the index for a 3-month term rather than a period of 6 months, it will become qualified for inclusion within the index.
- Depending on the companies’ free-float market capitalization, the final 20 companies will be chosen.
- When making the final decision, priority will be given to firms that can be traded in the futures and options part of the NSE.
Other Indices
| Indices Name | Price | Price Change (% change) |
|---|---|---|
| India VIX | 16.0975 | 0.11 (0.67%) |
| Nifty 10 Yr Benchmark G-Sec | 2412.77 | -0.27 (-0.01%) |
| Nifty 10 Yr Benchmark G-Sec (Clean Price) | 884.09 | -1.78 (-0.2%) |
| Nifty 100 | 24655.35 | 520.25 (2.16%) |
| Nifty 100 Equal Weight | 31252.45 | 543.6 (1.77%) |
Faqs
Which are currently the best pharma companies in India?
Cipla, Alkem, Sun Pharma, Torrent Pharma, and Dr. Reddy’s Laboratories are the current best pharma-based companies in India in terms of market capitalization.
How do I calculate Nifty Pharma?
Each stock’s weightage in the index is determined according to its free-float market capitalization, except for the top three stocks, whose combined weight cannot exceed 62% at the point of rebalancing (Index Rebalancing: The index is recalibrated every two years), and no separate stock should have a weightage greater than 33%.
How many companies are present in the Nifty 50 index?
The Nifty 50 Index comprises a total of 4 businesses from the Nifty Pharma Index. These companies are Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Divi’s Laboratories Ltd. and Sun Pharmaceuticals Ltd.
Is it risky to invest in pharma stocks?
Buying stocks of pharmaceutical companies can sometimes be risky due to the high costs and lengthy time between pharmaceutical research and approval (considering that the drug research procedure is successful and regulatory permission is given).
Should I start investing in pharmaceutical stocks?
Despite the instability, pharma businesses might be appealing to long-term traders. Traders can earn higher returns when they purchase at the correct time because the pharmaceutical industry is growing rapidly and has become increasingly important to daily life.
What is the cause behind the impulsive growth of the pharma sector?
Several pharma companies have experienced a spike in revenue due to authorities in the USA and other nations approving immunizations against the COVID-19 virus. The need for pharmaceutical stocks is rising; therefore, now is an excellent time to buy them.
What are the few major uses of Nifty Pharma?
There are several uses of Nifty Pharma in real-time. Still, the few major ones include the creation and implementation of structured products, index funds, ETFs, and benchmarking or evaluating mutual funds portfolios.
Latest News
- Nov 22, 2024
Enviro Infra Engineers' initial public offering (IPO) received strong investor interest on its first day. The IPO witnessed robust demand, reaching 2.08 times subscription by 5:19 PM on day one.
- Nov 22, 2024
Groww Multicap Fund - Direct (G) is a diversified equity mutual fund that invests across large-cap, mid-cap, and small-cap companies. It aims to capture growth opportunities in companies of varying market capitalizations and sectors, providing investors with a balanced portfolio. The fund's strategy leverages the potential of established large-cap companies for stability, while mid-cap and small-cap investments offer opportunities for higher growth.
- Nov 22, 2024
Kotak Transportation & Logistics Fund - Direct (G) is designed for investors seeking long-term capital appreciation by leveraging the performance of the Nifty Transportation & Logistics Total Return Index (TRI). With its diversified portfolio, the fund offers potential for steady returns while aligning with India's expanding infrastructure landscape.
- Nov 22, 2024
Indian equity markets closed lower on November 22, bolstered by value buying at lower levels and strong global cues. The Nifty and Sensex both posted notable gains, with the Sensex jumping over 2,000 points. The rally was fueled by a rebound in blue-chip bank stocks, a positive US labour market report, and recovery in Adani Group shares.
Latest Blogs
The NTPC Green Energy IPO allotment status is not available yet. The allotment date for the NTPC Green Energy IPO is 25 November 2024. The NTPC Green Energy IPO status will be updated once the basis of allotment is finalized. Please revisit this website for the latest updates and information.
- Nov 22, 2024
Nifty Prediction for 25th November The benchmark indices staged a strong recovery on Friday, gaining approximately 2.39% after a week-long decline, driven by heavyweights like Reliance, TCS, Infosys, and SBI. The market saw broad-based buying as both mid-cap and small-cap indices rose by around 1%. Key sectoral indices such as Nifty Realty, PSU Bank, and IT surged nearly 3% for the day, adding to the bullish momentum.
- Nov 22, 2024
Swing Trading Stocks for the Week iJoin the club of lakhs of tech savvy investors!
- Nov 22, 2024
Highlights • The Adani Power share continues to attract attention due to its promising performance in the energy sector. • Adani Power stock has shown resilience, making it a key player in India's power generation landscape. • Recent fluctuations in Adani Power stock price have sparked discussions among investors.
- Nov 22, 2024
